Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 112397595 | 11239759 | 5 | F | 20160823 | 20150706 | 20160901 | EXP | PHHY2015CA080905 | NOVARTIS | 0.00 | F | Y | 0.00000 | 20160902 | CN | COUNTRY NOT SPECIFIED | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 112397595 | 11239759 | 1 | PS | TASIGNA | NILOTINIB | 1 | Oral | 300 MG, BID | 22068 | 300 | MG | CAPSULE | BID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 112397595 | 11239759 | 1 | Chronic myeloid leukaemia |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 112397595 | 11239759 | Acne | |
| 112397595 | 11239759 | Alopecia | |
| 112397595 | 11239759 | Anxiety | |
| 112397595 | 11239759 | Asthenia | |
| 112397595 | 11239759 | Chest discomfort | |
| 112397595 | 11239759 | Constipation | |
| 112397595 | 11239759 | Diabetes mellitus | |
| 112397595 | 11239759 | Discomfort | |
| 112397595 | 11239759 | Dry skin | |
| 112397595 | 11239759 | Dyspepsia | |
| 112397595 | 11239759 | Hyperchlorhydria | |
| 112397595 | 11239759 | Impaired healing | |
| 112397595 | 11239759 | Nasopharyngitis | |
| 112397595 | 11239759 | Oropharyngeal pain | |
| 112397595 | 11239759 | Pain | |
| 112397595 | 11239759 | Pruritus | |
| 112397595 | 11239759 | Rash papular | |
| 112397595 | 11239759 | Secretion discharge | |
| 112397595 | 11239759 | Skin disorder | |
| 112397595 | 11239759 | Skin hypertrophy | |
| 112397595 | 11239759 | Urinary tract infection | |
| 112397595 | 11239759 | Uterine disorder | |
| 112397595 | 11239759 | Vaginal discharge | |
| 112397595 | 11239759 | Vaginal infection | |
| 112397595 | 11239759 | Vaginal lesion | |
| 112397595 | 11239759 | Vulvovaginal discomfort |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 112397595 | 11239759 | 1 | 20150512 | 0 |